[1] Benjafield A V,Ayas N T,Eastwood P R,et al.Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J].Lancet Reapir Med,2019,7(8):687-698.
[2] Azarbarzin A,Labarca G, Kwon Y,et al. Physiologic consequences of upper airway obstruction in sleep apnea[J].Chest,2024,166(5):1209-1217.
[3] Li L,Yang Y,Zhang H,et al.Salidroside ameliorated intermittent hypoxia-aggravated endothelial barrier disruption and atherosclerosis via the cAMP/PKA/RhoA signaling pathway[J].Front Pharmacol,2021,(12):723922.
[4] Chen L,Zou S,Wang J.Association of obstructive sleep apnea syndrome ( OSA/OSAHS) with coronary atherosclerosis risk: systematic review and meta-analysis[J].Comput Math Methods Med,2022,8905736.
[5] Benjafield A V, Ayas N T, Eastwood P R, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698.
[6] Veasey S C, Rosen I M. Obstructive sleep apnea in adults[J]. N Engl J Med, 2019, 380(15):1442-1449.
[7] Deol R,Lee K A,Kanaya A M, et al. Obstructive sleep apnea risk and subclinical atherosclerosis in South Asians living in the United States[J].Sleep Health,2020,6(1):124-130.
[8] Marra L,Cavallaro G,Lecce V D, et al.The association between dysphagia and OSA[J].Acta Otorhinolaryngol Ital,2022,42(1):82-88.
[9] Chew A Y,Lee C H. Obstructive sleep apnoea and coronary revascularisation outcomes[J].Asialntervention,2023,9(2):105-113.
[10] Feng K,Yang J,Liu K. Shared genetic associations and etiology between obstructive sleep apnea and CVDs: a genome-wide cross-trait analysis and bidirectional Mendelian randomization analysis[J].Eur J Prev Cardiol,2024,11(5):zwae347.
[11] Kheirandish-Gozal L,Gozal D.Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines[J].Int J Mol Sci,2019,20(3):459.
[12] Ma L,Zhang J,Liu Y. Roles and mechanisms of obstructive sleep apnea-hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective[J].Oxid Med Cell Longev,2016:8215082.
[13] Collen J,Lettieri C,Wickwire E,et al. Obstructive sleep apnea and cardiovascular disease, a story of confounders[J].Sleep Breath,2020,24(4):1299-1313.
[14] Zeng X,Guo R,Dong M,et al.Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression[J].J Transl Med,2018,16(1) :106.
[15] Maniaci A, Iannella G, Cocuzza S,et al.Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients[J]. J Clin Med,2021, 10(2):277.
[16] Rizzoni D,Ciuceis C D,Agabiti-Rosei C. Commentary on “Pathways of Microcirculatory Endothelial Dysfunction in OSA: A Comprehensive Ex Vivo Evaluation in Human Tissue”[J].Am J Hypertens,2022,35(4):309-310.
[17] 王亚芬,旷湘楠,尹玉洁,等.缺氧对阻塞性睡眠呼吸暂停综合征与动脉粥样硬化的影响[J] ,世界中医药,2021,16(11):1654-1657.
[18] Ahmad M,Makati D,Akbar S.Review of and updates on hypertension in obstructive sleep apnea[J].Int J Hypertens,2017:1848375.
[19] Cheng E T W,Chan R N C,Chan K C C,et al. Level of urinary catecholamine in children with sleep disordered breathing: a systematic review and meta-analysis[J].Sleep Med,2022,100(12):565-572.
[20] Somers V K,Dyken M E,Clary M P,et al.Sympathetic neural mechanisms in obstructive sleep apnea[J].J Clin Invest,1995,96(4):1897-1904.
[21] Shang F,Wang S C,Gongol B,et al.Obstructive sleep apnea-induced endothelial dysfunction is mediated by miR-210[J].Am J Respir Care Med,2023,207(3):323-325.
[22] Choi Y K.Detrimental roles of hypoxia-Inducible factor-1α in severe hypoxic brain diseases[J].Int J Mol Sci,2024,25(8):4465.
[23] Vageli D P,Doukas P G,Georgiou D,et al.HIF-1α and VEGF Immunophenotypes as potential biomarkers in the prognosis and evaluation of treatment efficacy of atherosclerosis: a systematic review of the literature[J].Front Biosci(Landmark Ed),2025,30(1):27004.
[24] Kyotani Y,Taksawa S,Yoshizumi M.Proliferative pathways of vascular smooth muscle cells in response to intermittent hypoxia[J].Int J Mol Sci,2019,20(11) :1-14.
[25] 杨 静,黄玲媚,吴 俊,等.血脂水平对预测阻塞性睡眠呼吸暂停低通气综合征病人合并高血压的价值分析[J].实用老年医学,2020,34(8):828-831.
[26] Drager L F,Polotsky V Y,lorenzi-Filho G.Obstructive sleep apnea:an emerging risk factor for atherosclerosis[J].Chest,2011,140(2):534-542.
[27] Kamble P G,Theorell-Haglow J,Wiklund U,et al. Sleep apnea in men is associated with altered lipid metabolism,glucose tolerance,insulin sensitivity,and body fat percentage[J]. Endocrine,2020,70(1):48-57.
[28] Yin H Y,Huang W,Yang B J. Association between METS-IR index and obstructive sleep apnea: evidence from NHANES[J]. Sci Rep,2025,15(1):6654.
[29] Qian Y J,Xu H J,Wang Y Y,et al. Obstructive sleep apnea predicts risk of metabolic syndrome independently of obesity:a meta-analysis[J]. Arch Med Sci,2016,12(5):1077-1087.
[30] Dominguez J E,Grotegut C A,Wright M C,et al. Obstructive sleep apnea among gravidas with chronic hypertension compared to matched controls: a prospective cohort study[J]. Anesth Analg, 2023, 136(2): 205-214.
[31] Chaudhary S C,Gupta P,Sawlani K K,et al.Obstructive sleep apnea in hypertension[J].Cureus,2023,15(4):e383229.
[32] Koo P, Muntner P, Hall M E, et al. Relationship between risks for obstructive sleep apnea, resistant hypertension, and aldosterone among African American adults in the jackson heart study[J]. Am J Hypertens, 2022, 35(10): 875-883.
[33] Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study[J]. BMJ, 2000, 320(7233): 479-482.
[34] Arnaud C,Bochaton T,Pépin J L, et al. Obstructive sleep apnoea and cardiovascular consequences: pathophysiological mechanisms[J]. Arch Cardiovasc Dis, 2020, 113(5):350-358.